COVID-19 Antibody Treatment Cleared for Emergency Use

Health and Human Services commits to placing drug where needed most.

The Food and Drug Administration cleared the experimental antibody treatment developed by Eli Lilly for emergency use last week. Health and Human Services Secretary Alex Azar announced that the U.S. government will work to get the medicine to underserved hospitals and individuals.

“Authorization and distribution of this new Eli Lilly antibody treatment is a significant step forward in treating patients and bridging us to the rollout of safe and effective vaccines,” said Secretary Azar. “Federal allocation of therapeutics like Lilly’s, in cooperation with our state and local government partners, will help ensure that they go to the patients who need them most just days after the product is authorized.”

HHS Assistant Secretary for Preparedness and Response Dr. Robert Kadlec said, “To that end, we are coordinating with Lilly, its distributor, and state and territorial health departments to get therapeutics into the hands of healthcare providers quickly, with a focus on areas of the country currently hardest hit by the pandemic.”

As the Lord Leads, Pray with Us…

  • For Secretary Azar as his department works to facilitate distribution of this medicine.
  • For the FDA as they screen new coronavirus therapeutics for emergency use.
  • For the president’s administration as more treatments are developed and authorized.

Sources: FDA, HHS, NewsMax


Back to top